Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 59Gynecologic 51Thoracic 32Gastrointestinal 29Genitourinary 7Head & Neck 6Sarcoma 4Dermatologic 4CNS 2Plasma cell 1Other solid neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Brain Neoplasms 2Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 171Bevacizumab 106Radiotherapy 87Radiation 38Cyclophosphamide 38Etoposide 34Carboplatin 34Magnetic Resonance Spectroscopy 32Irinotecan 32Radiosurgery 27Vincristine 25pembrolizumab 24Everolimus 23Cisplatin 23Nivolumab 22Radiotherapy, Intensity-Modulated 19Isotretinoin 19Filgrastim 19Erlotinib Hydrochloride 19Topotecan 18Lomustine 17Vorinostat 16Doxorubicin 16Granulocyte Colony-Stimulating Factor 15sargramostim 14antineoplaston A10 13Radiotherapy, Conformal 13antineoplaston AS 2-1 12Granulocyte-Macrophage Colony-Stimulating Factor 12dinutuximab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Taxes × CNS × Clear all
NCT04964960 2025-10-31

Pembro+Chemo in Brain Mets

University of Kentucky

Phase 2 Terminated
3 enrolled 7 charts
CNSThoracic

Brain Neoplasms, Lung Neoplasms, Neoplasms

NCT02073968 2024-01-25

PAINT

Albert Einstein College of Medicine

Phase 2 Completed
35 enrolled 13 charts
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡